Investing.com - McKesson (NYSE:MCK) reported on Monday second quarter earnings that beat analysts' forecasts and revenue that topped expectations.
McKesson announced earnings per share of $6.15 on revenue of $66.58B. Analysts polled by Investing.com anticipated EPS of $4.66 on revenue of $63.16B.
McKesson shares are down 19% from the beginning of the year and are trading at $214.00 , down-from-52-week-high.They are under-performing the S&P 500 which is up 22.83% from the start of the year.
McKesson shares gained 2.89% in after-hours trade the report.
McKesson follows other major Healthcare sector earnings this month
McKesson's report follows an earnings beat by J&J on Tuesday, October 19, 2021, who reported EPS of $2.6 on revenue of $23.34B, compared to forecasts EPS of $2.35 on revenue of $23.64B.
Thermo Fisher Scientific had beat expectations on Wednesday with third quarter EPS of $5.76 on revenue of $9.33B, compared to forecast for EPS of $4.68 on revenue of $8.38B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar